Shibuya M - Search Results

1

A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.

Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. Seetharam L, et al. Among authors: shibuya m. Oncogene. 1995 Jan 5;10(1):135-47. Oncogene. 1995. PMID: 7824266

2

Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis.

Shibuya M. Shibuya M. Angiogenesis. 2006;9(4):225-30; discussion 231. doi: 10.1007/s10456-006-9055-8. Epub 2006 Nov 16. Angiogenesis. 2006. PMID: 17109193 Review.

3

Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis.

Hara A, Wada T, Furuichi K, Sakai N, Kawachi H, Shimizu F, Shibuya M, Matsushima K, Yokoyama H, Egashira K, Kaneko S. Hara A, et al. Among authors: shibuya m. Kidney Int. 2006 Jun;69(11):1986-95. doi: 10.1038/sj.ki.5000439. Kidney Int. 2006. PMID: 16641924

4

[Anti-angiogenic reagents].

Shibuya M. Shibuya M. Tanpakushitsu Kakusan Koso. 2000 Apr;45(6 Suppl):1182-7. Tanpakushitsu Kakusan Koso. 2000. PMID: 10771693 Review. Japanese. No abstract available.

5

Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.

Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, Shibuya M. Sato Y, et al. Among authors: shibuya m. Ann N Y Acad Sci. 2000 May;902:201-5; discussion 205-7. doi: 10.1111/j.1749-6632.2000.tb06314.x. Ann N Y Acad Sci. 2000. PMID: 10865839 Review.

6

Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.

Williams YN, Masuda M, Sakurai-Yageta M, Maruyama T, Shibuya M, Murakami Y. Williams YN, et al. Among authors: shibuya m. Oncogene. 2006 Mar 9;25(10):1446-53. doi: 10.1038/sj.onc.1209192. Oncogene. 2006. PMID: 16261159

7

Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.

Huang L, Watanabe M, Chikamori M, Kido Y, Yamamoto T, Shibuya M, Gotoh N, Tsuchida N. Huang L, et al. Among authors: shibuya m. Oncogene. 2006 Oct 19;25(49):6457-66. doi: 10.1038/sj.onc.1209656. Epub 2006 May 15. Oncogene. 2006. PMID: 16702953

8

BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors.

Tsuchida R, Osawa T, Wang F, Nishii R, Das B, Tsuchida S, Muramatsu M, Takahashi T, Inoue T, Wada Y, Minami T, Yuasa Y, Shibuya M. Tsuchida R, et al. Among authors: shibuya m. Oncogene. 2014 Jul 17;33(29):3803-11. doi: 10.1038/onc.2013.358. Epub 2013 Sep 9. Oncogene. 2014. PMID: 24013228

9

Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling.

Tsuchida R, Das B, Yeger H, Koren G, Shibuya M, Thorner PS, Baruchel S, Malkin D. Tsuchida R, et al. Among authors: shibuya m. Oncogene. 2008 Jun 26;27(28):3923-34. doi: 10.1038/onc.2008.38. Epub 2008 Mar 10. Oncogene. 2008. PMID: 18332870

10

Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse.

Rosnet O, Stephenson D, Mattei MG, Marchetto S, Shibuya M, Chapman VM, Birnbaum D. Rosnet O, et al. Among authors: shibuya m. Oncogene. 1993 Jan;8(1):173-9. Oncogene. 1993. PMID: 8380915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results